| __timestamp | Eli Lilly and Company | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14683100000 | 23068000 |
| Thursday, January 1, 2015 | 14921500000 | 33277000 |
| Friday, January 1, 2016 | 15567200000 | 184902000 |
| Sunday, January 1, 2017 | 16801100000 | 437411000 |
| Monday, January 1, 2018 | 16811600000 | 827478000 |
| Tuesday, January 1, 2019 | 17598300000 | 934678000 |
| Wednesday, January 1, 2020 | 19056500000 | 951266000 |
| Friday, January 1, 2021 | 21005600000 | 1382097000 |
| Saturday, January 1, 2022 | 21911600000 | 1553153000 |
| Sunday, January 1, 2023 | 27041900000 | 1757661000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, Eli Lilly and Company and Exelixis, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Eli Lilly's gross profit surged by an impressive 84%, reflecting its robust growth and strategic advancements. In contrast, Exelixis, while smaller in scale, demonstrated a remarkable 7,500% increase in gross profit, showcasing its dynamic expansion and potential in the biotech sector.
Eli Lilly's consistent growth trajectory is a testament to its strong market presence and innovative pipeline. By 2023, its gross profit reached a peak, underscoring its leadership in the industry.
Exelixis, though starting from a modest base, has shown exponential growth, highlighting its potential to disrupt the market with groundbreaking therapies.
Eli Lilly and Company vs Vertex Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Gross Profit Comparison: Eli Lilly and Company and Sanofi Trends
Gross Profit Trends Compared: Eli Lilly and Company vs Teva Pharmaceutical Industries Limited
Gross Profit Comparison: Eli Lilly and Company and United Therapeutics Corporation Trends
Gross Profit Comparison: Eli Lilly and Company and Viatris Inc. Trends
Eli Lilly and Company vs Vericel Corporation: A Gross Profit Performance Breakdown
Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Novartis AG vs Exelixis, Inc.
Gross Profit Analysis: Comparing GSK plc and Exelixis, Inc.
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.
Key Insights on Gross Profit: Teva Pharmaceutical Industries Limited vs Exelixis, Inc.
Genmab A/S and Exelixis, Inc.: A Detailed Gross Profit Analysis